FATE vs POOL · rev $13.6M vs P/E 18, rev $5.31B
Fate Therapeutics Inc (FATE) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
FATE currently screens at market cap $331.0M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the FATE and POOL stock pages for the full models.
Not investment advice.